Filter Results:
(2,838)
Show Results For
- All HBS Web
(2,838)
- People (15)
- News (814)
- Research (1,603)
- Events (3)
- Multimedia (11)
- Faculty Publications (969)
Show Results For
- All HBS Web
(2,838)
- People (15)
- News (814)
- Research (1,603)
- Events (3)
- Multimedia (11)
- Faculty Publications (969)
- May 2010
- Supplement
Tremblant Capital Group Exhibits (CW)
By: Robin Greenwood
Brett Barakett, CEO and founder of Tremblant Capital Group, a New York-based hedge fund, must decide what to do with his fund's position in Green Mountain Coffee Roasters, which has dropped in value by more than 40 percent in recent months. Tremblant is a hedge fund... View Details
- Career Coach
Jonathan Shepherd
Jonathan is CPD's Corporate Relations Director overseeing principal investing: VC/PE, investment management and real estate. Since 2007, he has coached thousands of students & alumni and forged recruiting relationships with hundreds... View Details
Keywords: Angel Investing; Angel Investing; Angel Investing; Angel Investing; Angel Investing; Angel Investing; Angel Investing; Angel Investing; Angel Investing; Angel Investing; Angel Investing; Angel Investing; Angel Investing; Angel Investing; Angel Investing; Angel Investing; Angel Investing; Angel Investing; Angel Investing; Angel Investing; Angel Investing; Angel Investing; Angel Investing; Angel Investing; Angel Investing; Angel Investing; Angel Investing
- 06 Nov 2000
- Research & Ideas
The Determinants of Corporate Venture Capital Success
Corporate-sponsored venture funds first appeared in the 1960s, about two decades after the first flowering of the venture capital industry. Ever since, they have mirrored the cyclic nature of the industry as a whole. But there are... View Details
Keywords: by Paul Gompers & Josh Lerner
- 15 Jun 2016
- Research & Ideas
These VC Partners May Make Your Firm Less Innovative
much-needed cash but also expertise and advice. In a perfect world, everyone benefits. The VC firm takes an equity stake and makes money when the company succeeds, rewarding limited partners who have invested in the VC firm. But what... View Details
- 17 Feb 2014
- Research & Ideas
Companies Detangle from Legacy Pensions
nearly all corporations ceased offering defined benefit plans in favor of "defined contribution" packages such as 401(k) plans—in which employees contribute a set amount from their paychecks that would be individually invested... View Details
- September 2006 (Revised February 2011)
- Case
Empemex
By: Lynda M. Applegate and Regina Garcia-Cuellar
Studies an entrepreneurial venture in Mexico City. The protagonists, two MBAs from HBS, started a pawn shop chain funded from their private equity office after finishing business school. This is timed at a point where the protagonists have to decide how to grow the... View Details
Keywords: Developing Countries and Economies; Entrepreneurship; Venture Capital; Investment; Growth and Development Strategy; Mexico City; United States
Applegate, Lynda M., and Regina Garcia-Cuellar. "Empemex." Harvard Business School Case 807-031, September 2006. (Revised February 2011.)
- January 2023
- Case
Cleave Therapeutics: Taking a Risk on Oncology Drug Discovery
By: Regina Herzlinger and Brian Walker
What should a successful executive (HBS Baker Scholar) assess as her next move as the CEO of a firm with a promising and yet uncertain new drug? Amy Burroughs’ mandate to successfully commercialize Cleave Therapeutics’ drug for a cancer with no current successful... View Details
Keywords: Product Development; Leadership; Health Testing and Trials; Research and Development; Risk and Uncertainty; Financial Condition; Partners and Partnerships; Pharmaceutical Industry
Herzlinger, Regina, and Brian Walker. "Cleave Therapeutics: Taking a Risk on Oncology Drug Discovery." Harvard Business School Case 323-045, January 2023.
- March 2015 (Revised January 2024)
- Case
CV Ingenuity (A): How to Evaluate the Commercial Viability of New Health Care Technologies
By: Regina E. Herzlinger and Andrew Otazo
Duke Rohlen (HBS MBA ’01) hoped to win over a prominent venture capital investor for Series B financing of his firm CVI that was creating a drug-eluting balloon (DES) to treat peripheral arterial disease. As a second-mover, Duke felt he was more likely to acquire... View Details
Keywords: CV Ingenuity; CVI; Drug Eluting Balloon; DEB; Drug Eluting Stent; Angioplasty Balloon; FoxHollow; Medical Device; Medical Device Startup; Premarket Approval; PMA; Lutonix; Stellarex; LEVANT; ILLUMENATE; Clinical Trials; Peripheral Arterial Disease; PAD; Healthcare Startups; Covidien; Health Care and Treatment; Health Testing and Trials; Business Startups; Commercialization; Health Industry; Medical Devices and Supplies Industry; United States; Europe
Herzlinger, Regina E., and Andrew Otazo. "CV Ingenuity (A): How to Evaluate the Commercial Viability of New Health Care Technologies." Harvard Business School Case 315-045, March 2015. (Revised January 2024.)
- July 2003 (Revised September 2003)
- Case
Refinancing of Shanghai General Motors (B), The
By: Mihir A. Desai and Mark Veblen
This case provides the outcome to "The Refinancing of Shanghai General Motors (A)" in which the CFO of General Motors' joint venture in Shanghai, Shanghai General Motors (SGM), wants to refinance almost $900 million of project finance it raised to begin operations. The... View Details
Keywords: Business Subsidiaries; Multinational Firms and Management; Joint Ventures; Financing and Loans; Auto Industry; Shanghai
Desai, Mihir A., and Mark Veblen. "Refinancing of Shanghai General Motors (B), The." Harvard Business School Case 204-025, July 2003. (Revised September 2003.)
- 11 May 2021
- Blog Post
IPO or M&A? How Venture Capital Shapes a Startup's Future
Entrepreneurs rarely consider who will ultimately own their startups—and what that means for founders—when they court venture capitalists. New research suggests they should. A startup funded by VCs who tend to work with the same group of... View Details
Keywords: Venture Capital / Private Equity
- 20 Jan 2020
- News
Is Venture Capital Worth The Risk?
- 2024
- Working Paper
Does Private Equity Have Any Business Being in the Health Care Business?
By: Nori Gerardo Lietz and Zirui Song
Private Equity (“PE”) has come under increased scrutiny by the press, academics, and policymakers, as well as the public, for its investments in health care delivery. This scrutiny has been exacerbated by recent high profile hospital bankruptcies following PE... View Details
Lietz, Nori Gerardo, and Zirui Song. "Does Private Equity Have Any Business Being in the Health Care Business?" Harvard Business School Working Paper, No. 25-012, September 2024.
Dwight B. Crane
Mr. Crane was a member of the Finance Faculty at Harvard Business School for a number of years, working primarily in the field of financial institutions and corporate governance. He taught in the MBA and executive education programs at the School, most recently... View Details
- 02 Aug 2021
- Blog Post
ALUMNI WORK TO REVERSE BIAS THROUGH PHILANTHROPY
business and society. Two new ventures led by HBS alumni are leveraging the power of philanthropy in the fight against racism. By retooling traditional philanthropic models in distinctive ways, the New Commonwealth Racial Equity and Social Justice View Details
- 16 Mar 2021
- Blog Post
2+2 Where Are They Now Spotlight: Smitha Das (MBA 2018)
dedicated to mobilizing capital to drive social progress. In my role, I work on our strategy and social investment teams. I’ve helped develop our impact management and field building strategies and contribute to firm-wide fundraising... View Details
- 2012
- Other Unpublished Work
What Are We Meeting For? The Consequences of Private Meetings with Investors
By: Eugene F. Soltes and David H. Solomon
Executives of publicly-traded firms spend considerable time meeting privately with investors, despite regulation restricting their ability to convey material nonpublic information. Using a set of records of all one-on-one meetings between senior management and... View Details
Keywords: Decision Choices and Conditions; Investment; Investment Funds; Governing Rules, Regulations, and Reforms; Management Teams; Public Ownership; Business and Shareholder Relations
Soltes, Eugene F., and David H. Solomon. "What Are We Meeting For? The Consequences of Private Meetings with Investors." September 2012.
- March 2021 (Revised August 2021)
- Case
Nayana Mawilmada: Transforming Urban Development in Sri Lanka
By: Joshua D. Margolis and Mahima Rao-Kachroo
In February 2018, Nayana Mawilmada (Nayana), investment head for the Sri Lankan government’s ambitious $40 billion Megapolis project, must weigh an attractive job offer to move from the public sector to the private sector. A massive government project aimed at... View Details
Keywords: Change Management; Transformation; Decision Making; Public Sector; Experience and Expertise; Strategic Planning; Work-Life Balance; Transportation; Risk and Uncertainty; Power and Influence; Personal Development and Career; Real Estate Industry; Rail Industry; Transportation Industry; South Asia; Sri Lanka; Boston; Virginia; United States
Margolis, Joshua D., and Mahima Rao-Kachroo. "Nayana Mawilmada: Transforming Urban Development in Sri Lanka." Harvard Business School Case 421-065, March 2021. (Revised August 2021.)
- September 2019
- Teaching Note
Gun Safety in America: Three Leaders Propose Innovative Solutions
By: Rosabeth Moss Kanter and Joseph Paul
This is a teaching note to the original case: Gun violence was a significant problem in America. Three Harvard Advanced Leadership Initiative Fellows Christy Wood, Russell Sternlicht, and Gareth Glaser each decided to do something about gun safety. They each used... View Details
Keywords: Gun Violence; Guns; Advanced Leadership; Advanced Leadership Initiative; Innovation; Innovation & Entrepreneurship; Social Change; Social Responsibility; Leadership; Change Management; Experience and Expertise; Social Entrepreneurship; Values and Beliefs; Policy; Governing Rules, Regulations, and Reforms; Leading Change; Non-Governmental Organizations; Social Issues; Corporate Social Responsibility and Impact; United States
How to Build Workplaces That Protect Employee Health
John Macomber, senior lecturer at Harvard Business School and a veteran of the real estate industry, was studying ways to make workplaces safer for employees long before the Covid-19 crisis hit. Now that issues like air and water quality are top of... View Details
- 2021
- Working Paper
The Value of Intermediation in the Stock Market
By: Marco Di Maggio, Mark Egan and Francesco Franzoni
We estimate a structural model of broker choice to quantitatively decompose the value that institutional investors attach to broker services. Studying over 300 million institutional equity trades, we find that investors are sensitive to both explicit and implicit... View Details
Keywords: Financial Intermediation; Institutional Investors; Research Analysts; Broker Networks; Equity Trading; Institutional Investing; Financial Services Industry
Di Maggio, Marco, Mark Egan, and Francesco Franzoni. "The Value of Intermediation in the Stock Market." Harvard Business School Working Paper, No. 20-016, August 2019. (Revised June 2021. Accepted at the Journal of Financial Economics.)